miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery

Tanvir Alam, Leonard Lipovich
ISSN / E-ISSN
— / —
DOI
10.3390/ncrna7010018 ↗
Volume · Issue · Pages
7 · 1 · 18-18
Publisher
MDPI AG
Article URL
https://doi.org/10.3390/ncrna7010018 ↗
Article details
Unverified
Publication date (each date has its type and source)
02 Mar 2021
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date02 Mar 2021 OpenAlex

Keywords (as given): SARS-CoV-2; COVID-19 pandemic; microRNA; miR-122; hepatitis C virus; host-virus interaction; post-transcriptional regulation; RNA binding sites; airway epithelial cells; immune cells; drug repurposing

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Non-coding RNA
Publication date used
02 Mar 2021 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.